BR0114873A - Imidazopiridinas polissubstituìdas - Google Patents

Imidazopiridinas polissubstituìdas

Info

Publication number
BR0114873A
BR0114873A BR0114873-7A BR0114873A BR0114873A BR 0114873 A BR0114873 A BR 0114873A BR 0114873 A BR0114873 A BR 0114873A BR 0114873 A BR0114873 A BR 0114873A
Authority
BR
Brazil
Prior art keywords
imidazopyridines
polysubstituted
polysubstituted imidazopyridines
substituents
compounds
Prior art date
Application number
BR0114873-7A
Other languages
English (en)
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of BR0114873A publication Critical patent/BR0114873A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

"IMIDAZOPIRIDINAS POLISSUBSTITUìDAS". A presente invenção refere-se a imidazopiridinas de uma certa fórmula 1, na qual os substituintes e símbolos têm os significados indicados na descrição. Os compostos têm propriedades inibidoras de secreção gástrica.
BR0114873-7A 2000-10-25 2001-10-23 Imidazopiridinas polissubstituìdas BR0114873A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00123133 2000-10-25
PCT/EP2001/012207 WO2002034749A1 (en) 2000-10-25 2001-10-23 Polysubstituted imidazopyridines as gastric secretion inhibitors

Publications (1)

Publication Number Publication Date
BR0114873A true BR0114873A (pt) 2003-07-01

Family

ID=8170193

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0114873-7A BR0114873A (pt) 2000-10-25 2001-10-23 Imidazopiridinas polissubstituìdas

Country Status (19)

Country Link
US (2) US6869949B2 (pt)
EP (1) EP1332143A1 (pt)
JP (1) JP2004512338A (pt)
KR (1) KR20040011423A (pt)
CN (1) CN1692113A (pt)
AU (2) AU1056302A (pt)
BR (1) BR0114873A (pt)
CA (1) CA2426616A1 (pt)
EA (1) EA008151B1 (pt)
HR (1) HRP20030323A2 (pt)
HU (1) HUP0302308A2 (pt)
IL (1) IL154850A0 (pt)
MX (1) MXPA03003706A (pt)
NO (1) NO325736B1 (pt)
NZ (1) NZ525281A (pt)
PL (1) PL360412A1 (pt)
SK (1) SK5072003A3 (pt)
WO (1) WO2002034749A1 (pt)
ZA (1) ZA200302038B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6869949B2 (en) * 2000-10-25 2005-03-22 Altana Pharma Ag Polysubstituted imidazopyridines as gastric secretion inhibitors
DE10145457A1 (de) * 2001-09-14 2003-04-03 Basf Ag Substituierte Imidazo[1,2-a]-5,6,7,8-tetrahydropyridin-8-one, Verfahren zu ihrer Herstellung, sowie deren Verwendung zur Herstellung von Imidazo[1,2,-a]pyridinen
MXPA04007895A (es) 2002-02-15 2004-10-15 Altana Pharma Ag Compuestos n-acilo triciclicos.
TWI295575B (en) * 2002-04-24 2008-04-11 Altana Pharma Ag Nitrosated imidazopyridines
BR0316752A (pt) * 2002-12-20 2005-10-25 Altana Pharma Ag Silil éteres
MXPA05008490A (es) * 2003-02-17 2005-10-18 Altana Pharma Ag Combinaciones que contienen imidazopiridinas y su uso en el tratamiento de enfermedades gastrointestinales inflamatorias.
US20060194972A1 (en) * 2003-04-03 2006-08-31 Altana Pharma Ag Process for the production of imidazopyridin-8-ones
AR044129A1 (es) * 2003-05-06 2005-08-24 Altana Pharma Ag Compuestos intermedios de imidazopiridina. proceso de preparacion.
EP1974730A1 (en) 2003-11-03 2008-10-01 AstraZeneca AB Imidazo[1,2-a]pyridine derivatives for use in the treatment of sleep disturbance due to silent gastro-esophageal reflux
AR046893A1 (es) * 2003-12-16 2005-12-28 Altana Pharma Ag Bencimidazoles triciclicos
AR046941A1 (es) * 2003-12-19 2006-01-04 Altana Pharma Ag Imidazopiridinas triciclicas y su uso como inhibidores de secrecion de acido gastrico
AU2004298453A1 (en) 2003-12-19 2005-06-30 Altana Pharma Ag Intermediates for the preparation of tricyclic dihydropyrano -imidazo -pyridines derivatives
CA2582256A1 (en) * 2004-10-01 2006-04-13 Altana Pharma Ag Substituted tricyclic benzimidazoles
AR051375A1 (es) * 2004-10-15 2007-01-10 Altana Pharma Ag Imidazopiridinas difluoro substituidas
WO2008058990A1 (en) * 2006-11-16 2008-05-22 Nycomed Gmbh 7,7-disubstituted pyrano-[2,3-c]-imidazo-[1,2-a]-pyridine derivatives and their use as gastric acid secretion inhibitors
WO2012027240A1 (en) * 2010-08-23 2012-03-01 Schering Corporation Fused tricyclic inhibitors of mammalian target of rapamycin

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468400A (en) * 1982-12-20 1984-08-28 Schering Corporation Antiulcer tricyclic imidazo [1,2-a]pyridines
US4673679A (en) * 1986-05-14 1987-06-16 E. I. Du Pont De Nemours And Company Use of prodrugs of 3-hydroxymorphinans to prevent bitter taste upon buccal, nasal or sublingual administration
WO1992021341A1 (en) * 1991-05-31 1992-12-10 Pfizer Inc. Use of rapamycin prodrugs as immunosuppressant agents
DE4308095A1 (de) * 1993-03-13 1994-09-15 Hoechst Ag Prodrug-Derivate von Arzneimittelwirkstoffen mit Hydroxylgruppen, Verfahren zu deren Herstellung und ihre Verwendung
SE9401197D0 (sv) 1994-04-11 1994-04-11 Astra Ab Active compounds
PT971922E (pt) * 1997-03-24 2004-09-30 Altana Pharma Ag Compostos de tetra-hidropirido
WO1998042707A1 (en) * 1997-03-24 1998-10-01 Byk Gulden Lomberg Chemische Fabrik Gmbh Tetrahydropyrido compounds
ZA982445B (en) * 1997-03-24 1998-09-24 Byk Gulden Lomberg Chem Fab Tetrahydropyrido compounds
WO1998054188A1 (en) * 1997-05-28 1998-12-03 Byk Gulden Lomberg Chemische Fabrik Gmbh Fused dihydropyrans
EA005377B1 (ru) * 1998-09-23 2005-02-24 Алтана Фарма Аг ТЕТРАГИДРОИМИДАЗО [1,2-h][1,7] НАФТИРИДИНОВЫЕ СОЕДИНЕНИЯ
JP2002528548A (ja) * 1998-11-03 2002-09-03 ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング イミダゾナフチリジン
DK1173439T3 (da) * 1999-04-17 2003-09-08 Altana Pharma Ag Halogenalkoxy-imidazonaphthyridiner
AU783764B2 (en) * 2000-03-29 2005-12-01 Altana Pharma Ag Alkylated imidazopyridine derivatives
WO2001072755A1 (en) * 2000-03-29 2001-10-04 Altana Pharma Ag Pyrano[2,3-c]imidazo[-1,2-a]pyridine derivatives for the treatment of gastrointestinal disorders
IL151200A0 (en) * 2000-03-29 2003-04-10 Altana Pharma Ag Tricyclic imidazopyridine prodrug derivatives and pharmaceutical compositions containing the same
AU783724B2 (en) * 2000-03-29 2005-12-01 Altana Pharma Ag Tricyclic imidazopyridines
US6869949B2 (en) * 2000-10-25 2005-03-22 Altana Pharma Ag Polysubstituted imidazopyridines as gastric secretion inhibitors

Also Published As

Publication number Publication date
EA200300478A1 (ru) 2003-12-25
SK5072003A3 (en) 2003-09-11
NO325736B1 (no) 2008-07-14
AU2002210563B2 (en) 2007-03-01
WO2002034749A1 (en) 2002-05-02
JP2004512338A (ja) 2004-04-22
US20040214852A1 (en) 2004-10-28
HUP0302308A2 (hu) 2003-11-28
EA008151B1 (ru) 2007-04-27
US7141567B2 (en) 2006-11-28
NO20031830D0 (no) 2003-04-24
US6869949B2 (en) 2005-03-22
KR20040011423A (ko) 2004-02-05
IL154850A0 (en) 2003-10-31
EP1332143A1 (en) 2003-08-06
CA2426616A1 (en) 2002-05-02
ZA200302038B (en) 2004-04-22
PL360412A1 (en) 2004-09-06
CN1692113A (zh) 2005-11-02
NO20031830L (no) 2003-04-24
US20040106642A1 (en) 2004-06-03
HRP20030323A2 (hr) 2005-04-30
NZ525281A (en) 2004-11-26
AU1056302A (en) 2002-05-06
MXPA03003706A (es) 2005-01-25

Similar Documents

Publication Publication Date Title
BR0114873A (pt) Imidazopiridinas polissubstituìdas
ZA200309887B (en) Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents.
TR200100805T2 (tr) Tetrahidropiridoeterler
MY136141A (en) Novel hydantoin derivatives and pharmaceutical compositions useful as metalloproteinase inhibitors
BR0008056A (pt) Pirrolocarbazóis e isoindolonas cìclicas fundidas substituìdas
EP1466898A4 (en) INHIBITORS OF THE PRODUCTION / SEPARATION OF BETA-AMYLOIDS PROTEINS
BR0013110A (pt) Forma oral de administração contendo microorganismos probióticos
MXPA04006266A (es) Pirimidotriazinas como inhibidores de fosfatasa.
BR0211826A (pt) Imidazopiridinas tricìclicas
BR0109542A (pt) Derivados de imidazopirina alquilados
EA200200875A1 (ru) Пролекарства производных имидазопиридина
TR200201613T2 (tr) Antitümör tesirli 2-(1H-indol-3-il)-2-okso asetamidler
BRPI0408893A (pt) benzimidazóis cìclicos
EP1532131A4 (en) COMPOUNDS OF THE MOTILID TYPE
IL138688A0 (en) Certain heteroaryl substituted thiol inhibitors of endothelin-converting enzyme
SE9903290D0 (sv) Novel compounds
BR0316201A (pt) Imidazopiridinas 8-substituìdas
BRPI0416678A (pt) pirazolpirimidinas
TR200102334T2 (tr) Matris metaloproteinazların önleyicileri olarak pirimidin-2,4,6-trionlar.
BR0309462A (pt) Imidazopiridinas nitrosadas
MY130488A (en) Process for preparing 3,3',6,6'-tetraalkyl-2,2'-biphenols and 3,3',6,6'-tetraalkyl-5,5'-dihalo-2,2'-biphenols
TW200504068A (en) 6-substituted imidazopyrazines
PL345966A1 (en) N-substituted azabicycloheptane derivatives, production and use thereof
BR0000184A (pt) Processo para a preparação de compostos heterocìclicos
BR0211620A (pt) Imidazopiridinas substituìdas por alquila para o tratamento de distúrbios gastrointestinais

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A E 9A 2A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2077 DE 26/10/2010.